Insider Selling: Tenet Healthcare (NYSE:THC) EVP Sells $5,616,960.00 in Stock

Tenet Healthcare Corporation (NYSE:THC) EVP Thomas Arnst sold 24,000 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the completion of the sale, the executive vice president directly owned 8,012 shares of the company’s stock, valued at approximately $1,875,128.48. The trade was a 74.97% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.

Tenet Healthcare Price Performance

Shares of Tenet Healthcare stock opened at $240.88 on Friday. The company has a 50-day simple moving average of $209.41 and a two-hundred day simple moving average of $201.66. Tenet Healthcare Corporation has a twelve month low of $109.82 and a twelve month high of $247.21. The stock has a market capitalization of $20.95 billion, a price-to-earnings ratio of 15.55, a price-to-earnings-growth ratio of 1.21 and a beta of 1.39. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. The company had revenue of $5.53 billion during the quarter, compared to the consensus estimate of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm’s quarterly revenue was up 8.9% on a year-over-year basis. During the same period in the previous year, the business earned $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Analysts forecast that Tenet Healthcare Corporation will post 12.24 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Dorsey Wright & Associates acquired a new stake in shares of Tenet Healthcare during the 4th quarter valued at $10,750,000. Corient Private Wealth LLC boosted its stake in shares of Tenet Healthcare by 1,103.6% during the fourth quarter. Corient Private Wealth LLC now owns 45,847 shares of the company’s stock valued at $9,111,000 after purchasing an additional 42,038 shares in the last quarter. Mercer Global Advisors Inc. ADV grew its holdings in shares of Tenet Healthcare by 24.4% during the fourth quarter. Mercer Global Advisors Inc. ADV now owns 42,180 shares of the company’s stock worth $8,382,000 after purchasing an additional 8,273 shares during the last quarter. Vident Advisory LLC raised its holdings in Tenet Healthcare by 6.3% in the 4th quarter. Vident Advisory LLC now owns 2,185 shares of the company’s stock valued at $434,000 after buying an additional 129 shares during the last quarter. Finally, State of Tennessee Department of Treasury boosted its position in Tenet Healthcare by 0.6% during the 4th quarter. State of Tennessee Department of Treasury now owns 37,491 shares of the company’s stock worth $7,096,000 after buying an additional 223 shares during the period. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms recently commented on THC. Guggenheim boosted their price target on Tenet Healthcare from $257.00 to $271.00 and gave the company a “buy” rating in a research note on Friday, February 13th. Barclays boosted their target price on shares of Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a research report on Friday, February 13th. Morgan Stanley reiterated an “overweight” rating and set a $260.00 price target on shares of Tenet Healthcare in a research report on Thursday, February 12th. Cantor Fitzgerald restated an “overweight” rating on shares of Tenet Healthcare in a research report on Wednesday. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and issued a $265.00 target price on shares of Tenet Healthcare in a report on Monday, February 16th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $247.67.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.